References
- GonçalvesMSSilveiraAFTeixeiraARHyppolitoMAMechanisms of cisplatin ototoxicity: theoretical reviewJ Laryngol Otol2013127653654123651576
- SchweitzerVGCisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agentsLaryngoscope19931034 Pt 21528464301
- Benedetti PaniciPGreggiSScambiaGEfficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-upInt J Gynecol Cancer199331445311578321
- EiamprapaiPYamamotoNHiraumiHEffect of cisplatin on distortion product otoacoustic emissions in Japanese patientsLaryngoscope201212261392139622555987
- LiYWomerRBSilberJHPredicting cisplatin ototoxicity in children: the influence of age and the cumulative doseEur J Cancer200440162445245115519518
- MenerDJBetzJGentherDJChenDLinFRHearing loss and depression in older adultsJ Am Geriatr Soc20136191627162924028365
- MarshakTSteinerMKaminerMLevyLShupakAPrevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled studyOtolaryngol Head Neck Surg2014150698399024618499
- RybakLPWhitworthCAOtotoxicity: therapeutic opportunitiesDrug Discov Today200510191313132116214676
- Van De WaterTRAbi HachemRNDinhCTConservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanismsCochlear Implants Int201011Suppl 1425521756583
- WaissbluthSSalehiPHeXDanielSJSystemic dexamethasone for the prevention of cisplatin-induced ototoxicityEur Arch Otorhinolaryngol201327051597160522907029
- HerrIUcurEHerzerKGlucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomasCancer Res200363123112312012810637
- ChandrasekharSSRubinsteinRYKwartlerJADexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agentsOtolaryngol Head Neck Surg2000122452152810740171
- McCallAASwanEEBorensteinJTSewellWFKujawaSGMcKennaMJDrug delivery for treatment of inner ear disease: current state of knowledgeEar Hear201031215616519952751
- CalliCPinarEOncelSAlper BagriyanikHUmut SakaryaERecovery of hearing in Cisplatin-induced ototoxicity in the Guinea pig with intratympanic dexamethasoneIndian J Otolaryngol Head Neck Surg2012641465023449759
- ShafikAGElkabarityRHThabetMTSolimanNBKallenyNKEffect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigsAuris Nasus Larynx2013401516022884636
- MurphyDDanielSJIntratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig modelOtolaryngol Head Neck Surg2011145345245721521888
- HillGWMorestDKParhamKCisplatin-induced ototoxicity: effect of intratympanic dexamethasone injectionsOtol Neurotol20082971005101118716567
- TruneDRCanlonBCorticosteroid therapy for hearing and balance disordersAnat Rec (Hoboken)2012295111928194323044978
- RuttALHawkshawMJSataloffRTIncidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubesEar Nose Throat J2011904E2121500156
- SlatteryWHFisherLMIqbalZFriedmanRALiuNIntratympanic steroid injection for treatment of idiopathic sudden hearing lossOtolaryngol Head Neck Surg2005133225125916087024
- BuckiováDRanjanSNewmanTAMinimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membraneNanomedicine (Lond)2012791339135422475648
- YuDHLuQXieJFangCChenHZPeptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculatureBiomaterials20103182278229220053444
- BirdPABeggEJZhangMKeastATMurrayDPBalkanyTJIntratympanic versus intravenous delivery of methylprednisolone to cochlear perilymphOtol Neurotol20072881124113018043438
- GaoCPanJLuWZhangMZhouLTianJIn-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cellsAnticancer Drugs200920980781419696655
- MüllerMvon HünerbeinKHoidisSSmoldersJWA physiological place-frequency map of the cochlea in the CBA/J mouseHear Res20052021–2637315811700
- RybakLPMukherjeaDJajooSRamkumarVCisplatin ototoxicity and protection: clinical and experimental studiesTohoku J Exp Med2009219317718619851045
- MeltserICanlonBProtecting the auditory system with glucocorticoidsHear Res20112811–2475521718769
- HorieRTSakamotoTNakagawaTIshiharaTHigakiMItoJStealth-nanoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing lossNanomedicine (Lond)2010591331134021128717
- BoweSNJacobARound window perfusion dynamics: implications for intracochlear therapyCurr Opin Otolaryngol Head Neck Surg201018537738520808222
- AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
- OhyamaKSaltANThalmannRVolume flow rate of perilymph in the guinea-pig cochleaHear Res1988352–31191293198505
- FengLWuHMaPMumperRJBenhabbourSRDevelopment and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivoInt J Nanomedicine201162545255622072889
- García-BerrocalJRNevadoJRamírez-CamachoRThe anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner earBr J Pharmacol200715271012102017906689
- BokemeyerCBergerCCHartmannJTAnalysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancerBr J Cancer1998778135513629579846